JOHNSON & JOHNSON

Q2 2025 13F Holdings

  • Location
    new brunswick, NJ
  • Num holdings

    20

  • Value ($000)

    $334,096

  • Date Filed
    07/22/2025
  • Form type
    13F-HR
  • CIK
    0000200406
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
PTGX
PTGX

Protagonist Therapeutics Inc.

COM
74366E102
$136.40M
41 %

2,449,183

---

MeiraGTx Holdings plc

COM
G59665102
$43.90M
13 %

6,641,064

RAPP
RAPP

Rapport Therapeutics, Inc.

COM
75383L102
$28.55M
9 %

2,498,051

LEGN
LEGN

Legend Biotech Corporation

SPONSORED ADS
52490G102
$28.21M
8 %

814,586

NBTX
NBTX

Nanobiotix S.A.

SPONSORED ADS
63009J107
$25.45M
8 %

5,623,816

CVRX
CVRX

CVRx, Inc.

COM
126638105
$23.88M
7 %

4,103,430

PRCT
PRCT

Procept BioRobotics Corporation

COM
74276L105
$20.37M
6 %

357,939

CTNM
CTNM

Contineum Therapeutics Inc.

CL A
21217B100
$8.13M
2 %

1,979,173

XNCR
XNCR

Xencor, Inc.

COM
98401F105
$6.09M
2 %

748,062

ARWR
ARWR

Arrowhead Pharmaceuticals, Inc.

COM
04280A100
$3.98M
1 %

247,598

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 20